China Ai-based Clinical Trials Solution Provider Market Size & Outlook
China ai-based clinical trials solution provider market, 2018-2030 (US$M)
Related Markets
China ai-based clinical trials solution provider market highlights
- The China ai-based clinical trials solution provider market generated a revenue of USD 63.9 million in 2021 and is expected to reach USD 724.3 million by 2030.
- The China market is expected to grow at a CAGR of 31% from 2022 to 2030.
- In terms of segment, oncology was the largest revenue generating therapeutic applications in 2021.
- CVD is the most lucrative therapeutic applications segment registering the fastest growth during the forecast period.
Ai-based clinical trials solution provider market data book summary
| Market revenue in 2021 | USD 63.9 million |
| Market revenue in 2030 | USD 724.3 million |
| Growth rate | 31% (CAGR from 2021 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | CVD |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
| Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
Other key industry trends
- In terms of revenue, China accounted for 4.8% of the global ai-based clinical trials solution provider market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China ai-based clinical trials solution provider market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 123.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
AI-based Clinical Trials Solution Provider Market Scope
AI-based Clinical Trials Solution Provider Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China ai-based clinical trials solution provider market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.16% in 2021. Horizon Databook has segmented the China ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
China is also a lucrative market and accounted for 31.9% of APAC AI-based clinical trials solution providers market in 2020. This growth can be attributed to growing government initiatives to regulate clinical trials as per global standards and better infrastructure, technological developments with respect to clinical research, and increasing number of patients opting for clinical trials.
Presence of large population, rapid economic growth, increasing interest of the government to invest in R&D, and presence of around 750 companies with research centers in China are among factors contributing to market growth.
The government has pledged to dedicate USD 18 billion to emerging biotechnologies in the latest five-year plan. These factors are likely to boost the market growth in the coming years.
Reasons to subscribe to China ai-based clinical trials solution provider market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China ai-based clinical trials solution provider market databook
-
Our clientele includes a mix of ai-based clinical trials solution provider market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into China ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China artificial intelligence based clinical trials solution provider market size, by therapeutic applications, 2018-2030 (US$M)
China AI-based Clinical Trials Solution Provider Market Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
